Dupilumab Drug Substance from Canada
Dupilumab IL-4/IL-13 inhibitor for atopic dermatitis and asthma. Biotech unmixed immunological HTS 3002.13.0090.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Dual cytokine specificity docs
• -80°C preferred storage
• No diagnostic claims